ABSTRACT
The HLA class II histocompatibility antigen gamma chain, also known as HLA-DR antigen-associated invariant chain or CD74, has been shown to be involved in many biological processes amongst which antigen loading and transport of MHC class II molecules from the endoplasmic reticulum to the Golgi complex. It is also part of a receptor complex for macrophage migration inhibitory factor (MIF), and participates in inflammatory signaling. The inhibition of MIF-CD74 complex formation is regarded as a potentially attractive therapeutic target in inflammation, cancer and immune diseases. In order to be able to produce large quantities of the extracellular moiety of human CD74, which has been reported to be unstable and protease-sensitive, different constructs were made as fusions with two solubility enhancers: the well-known maltose-binding domain and Fh8, a small protein secreted by the parasite Fasciola hepatica. The fusion proteins could be purified with high yields from Escherichia coli and were demonstrated to be active in binding to MIF. Moreover, our results strongly suggest that the MIF binding site is located in the sequence between the transmembrane and the membrane-distal trimerisation domain of CD74, and comprises at least amino acids 113-125 of CD74.
Subject(s)
Antigens, Differentiation, B-Lymphocyte/isolation & purification , Histocompatibility Antigens Class II/isolation & purification , Intramolecular Oxidoreductases/isolation & purification , Macrophage Migration-Inhibitory Factors/isolation & purification , Peptides/chemistry , Amino Acids/genetics , Animals , Antigens, Differentiation, B-Lymphocyte/chemistry , Antigens, Differentiation, B-Lymphocyte/genetics , Endoplasmic Reticulum/genetics , Escherichia coli/genetics , Fasciola hepatica/chemistry , Golgi Apparatus/genetics , HLA-DR Antigens/chemistry , HLA-DR Antigens/genetics , Histocompatibility Antigens Class II/chemistry , Histocompatibility Antigens Class II/genetics , Humans , Intramolecular Oxidoreductases/chemistry , Intramolecular Oxidoreductases/genetics , Macrophage Migration-Inhibitory Factors/chemistry , Macrophage Migration-Inhibitory Factors/genetics , Peptides/genetics , Protein Binding , SolubilityABSTRACT
BACKGROUND & OBJECTIVES: Different developmental stages of Wuchereria bancrofti, the major causal organism of lymphatic filariasis (LF), are difficult to obtain. Beside this limitation, to obtain complete coding sequence (CDS) of a gene one has to isolate mRNA and perform subsequent cDNA synthesis which is laborious and not successful at times. In this study, an alternative strategy employing polymerase chain reaction (PCR) was optimized and validated, to generate CDS of Macrophage migration Inhibitory Factor-2 (wbMIF-2), a gene expressed in the transition stage between L3 to L4. METHODS: The genomic DNA of W. bancrofti microfilariae was extracted and used to amplify the full length wbMIF-2 gene (4.275 kb). This amplified product was used as a template for amplifying the exons separately, using the overlapping primers, which were then assembled through another round of PCR. RESULTS: A simple strategy was developed based on PCR, which is used routinely in molecular biology laboratories. The amplified CDS of 363 bp of wbMIF-2 generated using genomic DNA splicing technique was devoid of any intronic sequence. INTERPRETATION & CONCLUSIONS: The cDNA of wbMIF-2 gene was successfully amplified from genomic DNA of microfilarial stage of W. bancrofti thus circumventing the use of inaccessible L3-L4 transitional stage of this parasite. This strategy is useful for generating CDS of genes from parasites that have restricted availability.
Subject(s)
Elephantiasis, Filarial/diagnosis , Elephantiasis, Filarial/genetics , Macrophage Migration-Inhibitory Factors/genetics , Wuchereria bancrofti/genetics , Animals , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Elephantiasis, Filarial/parasitology , Exons/genetics , Humans , Macrophage Migration-Inhibitory Factors/isolation & purification , Polymerase Chain Reaction , Wuchereria bancrofti/isolation & purification , Wuchereria bancrofti/pathogenicityABSTRACT
The macrophage migration inhibitory factors (MIFs) from the filarial parasite Onchocerca volvulus (OvMIF) were compared to the MIFs from the free-living nematode Caenorhabditis elegans (CeMIF) with respect to molecular, biochemical and immunological properties. Except for CeMIF-4, all other MIFs demonstrated tautomerase activity. Surprisingly, OvMIF-1 displayed oxidoreductase activity. The strongest immunostaining for OvMIF-1 was observed in the outer cellular covering of the adult worm body, the syncytial hypodermis; moderate immunostaining was observed in the uterine wall. The generation of a strong humoral immune response towards OvMIF-1 and reduced reactivity to OvMIF-2 was indicated by high IgG levels in patients infected with O. volvulus and cows infected with the closely related Onchocerca ochengi, both MIFs revealing identical amino acid sequences. Using Litomosoides sigmodontis-infected mice, a laboratory model for filarial infection, MIFs derived from the tissue-dwelling O. volvulus, the rodent gut-dwelling Strongyloides ratti and from free-living C. elegans were recognized, suggesting that L. sigmodontis MIF-specific IgM and IgG1 were produced during L. sigmodontis infection of mice and cross-reacted with all MIF proteins tested. Thus, MIF apparently functions as a target of B cell response during nematode infection, but in the natural Onchocerca-specific human and bovine infection, the induced antibodies can discriminate between MIFs derived from parasitic or free-living nematodes.
Subject(s)
Caenorhabditis elegans/metabolism , Macrophage Migration-Inhibitory Factors/metabolism , Onchocerca volvulus/metabolism , Amino Acid Sequence , Animals , Antibodies, Helminth/biosynthesis , Caenorhabditis elegans/genetics , Caenorhabditis elegans/immunology , Cattle , Cross Reactions , Female , Filariasis/immunology , Filariasis/parasitology , Filarioidea/immunology , Filarioidea/physiology , Humans , Immunity, Humoral , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/immunology , Macrophage Migration-Inhibitory Factors/isolation & purification , Male , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Onchocerca volvulus/genetics , Onchocerca volvulus/immunology , Onchocerciasis/immunology , Onchocerciasis/parasitology , Recombinant Proteins , Sequence Alignment , Sequence Analysis, DNA , Sigmodontinae , Substrate SpecificityABSTRACT
Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine produced by many mammalian tissues including skin. It is also found in many invertebrate parasites of mammals including ticks and may function to aid the parasite to evade the innate and adaptive immune responses in the host. In this study, the cDNA for a MIF gene was sequenced from Sarcoptes scabiei, the scabies mite, using RT-PCR and RACE molecular techniques. The resulting nucleotide sequence had a length of 405 base pairs and the putative amino acid sequences for the mite and tick (Dermacentor variabilis) proteins were identical. The initial steps for the project resulted in the production of expressed scabies mite cDNAs. A real time (qPCR) assay was performed with MIF from scabies mites and various tick species. Results show that mRNA encoding MIF homologues was three times more abundant in the mite samples when compared to RNA prepared from D. variabilis salivary glands and 1.3 times more abundant when compared with RNA prepared from D. variabilis midgut.
Subject(s)
Macrophage Migration-Inhibitory Factors/isolation & purification , Sarcoptes scabiei/chemistry , Amino Acid Sequence , Animals , Base Sequence , DNA Primers , DNA, Complementary/chemistry , Dermacentor/chemistry , Electrophoresis, Gel, Two-Dimensional , Female , Gene Expression Regulation , Macrophage Migration-Inhibitory Factors/chemistry , Macrophage Migration-Inhibitory Factors/genetics , Molecular Sequence Data , RNA/chemistry , RNA/isolation & purification , RNA, Ribosomal, 18S/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sarcoptes scabiei/genetics , Sequence AlignmentABSTRACT
Strongyloidiasis is a tropical parasitosis characterized by an alternation between free-living and parasitic stages, and by long-term infection via autoinfection. Since invasion and evasion processes of helminth parasites are substantially attained by the involvement of excretory-secretory products, we identified and characterized the 13.5 kDa macrophage migration inhibitory factor (MIF)-like protein in Strongyloides ratti. Sra-MIF is mainly secreted from the infective stage larvae (iL3), while the transcript was found at lower levels in parasitic and free-living females. Sequence analysis of the full-length cDNA showed the highest homology to the human pathogen Strongyloides stercoralis, and both are related to the MIF type-2. Unlike other mif genes, the Sra-mif includes no intron. The protein was recombinantly expressed in Escherichia coli and purified. Sra-MIF exhibited no in vitro tautomerase activity. The exposure of Sra-MIF to the host immune system is confirmed by high IgG reactivities found in the hosts' sera following infection or immunization. Flow cytometric analysis indicated the binding of Sra-MIF to the monocytes/macrophage lineage but not to peripheral lymphocytes. After exposure to Sra-MIF, monocytes released IL-10 but not TNF-alpha suggesting the involvement of the secreted parasite MIF in host immune responses.
Subject(s)
Helminth Proteins/immunology , Host-Parasite Interactions , Macrophage Migration-Inhibitory Factors/immunology , Strongyloides ratti/immunology , Amino Acid Sequence , Animals , Antigens, Helminth/genetics , Antigens, Helminth/immunology , Antigens, Helminth/isolation & purification , Cell Movement , Cross Reactions , Escherichia coli/chemistry , Escherichia coli/genetics , Female , Flow Cytometry , Helminth Proteins/genetics , Helminth Proteins/isolation & purification , Humans , Immunoglobulin G/blood , Interleukin-10/metabolism , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophages/immunology , Male , Molecular Sequence Data , Monocytes/immunology , Phylogeny , Rats, Wistar , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , Strongyloides ratti/genetics , Strongyloides ratti/pathogenicity , Strongyloidiasis/immunology , Strongyloidiasis/parasitology , Tumor Necrosis Factor-alpha/immunologyABSTRACT
BACKGROUND: In a previous study, we demonstrated that the human macrophage migration inhibitory factor (MIF)-like protein (As-MIF) isolated from helminths could inhibit allergic airway inflammation via the recruitment of CD4(+)CD25(+)Foxp3(+) T cells. OBJECTIVE: To evaluate the clinical importance of As-MIF as an antiasthma drug, we evaluated immune responses after recombinant As-MIF (rAs-MIF) treatment in peripheral blood mononuclear cell (PBMC) cultures. METHODS: PBMC was isolated from 10 patients with atopic asthma, 8 patients with nonatopic asthma, and 12 nonatopic healthy subjects, and various concentrations of rAs-MIF were transferred into the PBMC culture medium. After 3 days, we measured the levels of T helper 2 and T helper 1 cytokines via ELISA. RESULTS: In atopic asthma, IL-4 and IL-5 production was significantly reduced in the PBMC cultures after rAs-MIF treatment. These inhibitory effects were not observed in the nonatopic asthma group. By way of contrast, IL-10 production in the PMBC cultures was significantly increased after rAs-MIF treatment in all experimental groups. CONCLUSION: The results of this study are similar to those previously reported in a mouse study, suggesting that As-MIF might be a candidate for the specific treatment of asthma.
Subject(s)
Asthma/drug therapy , Cytokines/metabolism , Helminths/chemistry , Leukocytes, Mononuclear/drug effects , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/pharmacology , Th2 Cells/drug effects , Adult , Animals , Asthma/blood , Asthma/immunology , Case-Control Studies , Cells, Cultured , Cytokines/drug effects , Enzyme-Linked Immunosorbent Assay , Female , Humans , Hypersensitivity, Immediate/drug therapy , Hypersensitivity, Immediate/immunology , Interleukin-10/analysis , Interleukin-10/metabolism , Interleukin-4/analysis , Interleukin-4/metabolism , Interleukin-5/analysis , Interleukin-5/metabolism , Leukocytes, Mononuclear/immunology , Macrophage Migration-Inhibitory Factors/immunology , Male , Middle Aged , Th2 Cells/immunology , Th2 Cells/metabolism , Young AdultABSTRACT
In a previous study, we cloned type II MIFs (As-MIF) from Anisakis simplex 3rd stage larva and expressed a recombinant protein that suppressed allergic airway inflammation via regulatory T (CD4(+) CD25(+) Foxp3(+) T; T(reg) )-cell recruitment. In this study, in an effort to evaluate the function of rAs-MIF on another immune disease, we induced intestinal inflammation in mice using dextran sodium sulphate (DSS) with or without the application of rAs-MIF treatment to the mice. As a consequence, weight losses were recovered, and the value of disease activity index (DAI) was reduced by rAs-MIF treatment during the experimental period. The levels of TGF-ß and IL-10 in the spleens and mesenteric lymph nodes (MLN) from the rAs-MIF-treated mice were higher, but the levels of IFN-γ, IL-6 and IL-13 were lower than those of the mice treated with DSS but not with rAs-MIF. Additionally, the T(reg) cells observed were greatly increased in the MLNs of the rAs-MIF-treated mice than those of mice not treated with rAs-MIF. The results of our in vitro experiments showed that the elevated IL-10 production induced by rAs-MIF was generated via toll-like receptor 2. In conclusion, rAs-MIF appears to ameliorate DSS-induced colitis and may prove useful as a therapeutic agent for the treatment of intestinal inflammatory disease.
Subject(s)
Anisakis/chemistry , Colitis/drug therapy , Helminth Proteins/administration & dosage , Immunologic Factors/administration & dosage , Macrophage Migration-Inhibitory Factors/administration & dosage , Toll-Like Receptor 2/immunology , Animals , Body Weight , Colitis/chemically induced , Cytokines/analysis , Dextran Sulfate/administration & dosage , Dextran Sulfate/toxicity , Female , Helminth Proteins/isolation & purification , Immunologic Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/isolation & purification , Mice , Mice, Inbred C57BL , Severity of Illness Index , Spleen/immunology , Toll-Like Receptor 2/metabolism , Treatment OutcomeABSTRACT
Macrophage migration inhibitory factor (MIF) is a homotrimeric multifunctional proinflammatory cytokine that has been implicated in the pathogenesis of several inflammatory and autoimmune diseases. Current therapeutic strategies for targeting MIF focus on developing inhibitors of its tautomerase activity or modulating its biological activities using anti-MIF neutralizing antibodies. Herein we report a new class of isothiocyanate (ITC)-based irreversible inhibitors of MIF. Modification by benzyl isothiocyanate (BITC) and related analogues occurred at the N-terminal catalytic proline residue without any effect on the oligomerization state of MIF. Different alkyl and arylalkyl ITCs modified MIF with nearly the same efficiency as BITC. To elucidate the mechanism of action, we performed detailed biochemical, biophysical, and structural studies to determine the effect of BITC and its analogues on the conformational state, quaternary structure, catalytic activity, receptor binding, and biological activity of MIF. Light scattering, analytical ultracentrifugation, and NMR studies on unmodified and ITC-modified MIF demonstrated that modification of Pro1 alters the tertiary, but not the secondary or quaternary, structure of the trimer without affecting its thermodynamic stability. BITC induced drastic effects on the tertiary structure of MIF, in particular residues that cluster around Pro1 and constitute the tautomerase active site. These changes in tertiary structure and the loss of catalytic activity translated into a reduction in MIF receptor binding activity, MIF-mediated glucocorticoid overriding, and MIF-induced Akt phosphorylation. Together, these findings highlight the role of tertiary structure in modulating the biochemical and biological activities of MIF and present new opportunities for modulating MIF biological activities in vivo.
Subject(s)
Isothiocyanates/pharmacology , Macrophage Migration-Inhibitory Factors/antagonists & inhibitors , Macrophage Migration-Inhibitory Factors/chemistry , Autoimmune Diseases/physiopathology , Chromatography, Gel , Cytokines/chemistry , Glucocorticoids/pharmacology , Humans , Inflammation/physiopathology , Intramolecular Oxidoreductases/antagonists & inhibitors , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/isolation & purification , Models, Molecular , Phosphorylation , Protein Conformation , Scattering, Radiation , Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationABSTRACT
Polyhistidine-tag (His-tag) is a powerful tool for purification of recombinant protein. His-tagged protein can be affinity-purified by using resins immobilizing Ni2+ or anti-His-tag antibodies. However, Ni2+-affinity-purification is prevented by the presence of divalent cations. The purification with antibodies has contamination of antibody peptides, which interferes with following analysis. In the present study, we isolated RNA aptamers binding to His-tag. The best clone, named shot47, bound to the target with low picomolar dissociation constant. In the presence of divalent cations, shot47 was substitutable for antibodies against His-tag on ELISA, immunoprecipitation, and Western blotting. Shot47 can be synthesized easily by in vitro transcription. Thus, shot47 would be applicable as a useful and cost-effective tool for biochemical analyses.
Subject(s)
Aptamers, Nucleotide/chemistry , Chromatography, Affinity , Histidine/chemistry , Proteins/isolation & purification , RNA/chemistry , Antibodies/chemistry , Antibodies/immunology , Aptamers, Nucleotide/isolation & purification , Base Sequence , Macrophage Migration-Inhibitory Factors/isolation & purification , Nucleic Acid Conformation , Proteins/chemistry , RNA/isolation & purificationABSTRACT
Macrophage migration inhibitory factor (MIF) is found in immune-privileged sites and inhibits cytotoxicity mediated by CD3-ve lymphokine-activated killer cells (LAK). The mechanism by which MIF attenuates LAK cytotoxicity is unknown. We provide evidence that MIF has a major histocompatibility complex (MHC) class I-like motif. A monoclonal antibody (OX18) that binds a conserved region of rat MHC class I proteins binds native MIF. Anti-MIF polyclonal antibodies bind MHC class I. Epitope mapping suggests OX18 binds a loop of MHC class I bound by several receptors for MHC class I. A sequence (PRPEG) within the proposed OX18-binding site on MHC class I exists with a short insertion in MIF. OX18 does not bind MIF that is denatured by SDS-PAGE. This suggests the OX18 epitope is dependent on higher order structure in MIF. Interestingly, MIF inhibits binding of tetramers of MHC class I (H2D(b)) to LAK cells, suggesting it may bind to receptors for MHC class I. MIF may be an example where small regions of MHC class I are used by endogenous and viral proteins to control cytotoxicity mediated by immune cells.
Subject(s)
Histocompatibility Antigens Class I/immunology , Intramolecular Oxidoreductases/immunology , Killer Cells, Lymphokine-Activated/immunology , Macrophage Migration-Inhibitory Factors/immunology , Amino Acid Motifs , Animals , Antibodies, Monoclonal/immunology , Blotting, Western , Epitope Mapping , Humans , Intramolecular Oxidoreductases/isolation & purification , Macrophage Migration-Inhibitory Factors/isolation & purification , Male , Mice , Mice, Inbred BALB C , Models, Molecular , Molecular Sequence Data , RatsABSTRACT
BACKGROUND: Macrophage-migration inhibitory factor (MIF), one of the first cytokines described, has a broad range of proinflammatory properties. The genome sequencing project of Plasmodium falciparum identified a parasite homologue of MIF. The protein is expressed during the asexual blood stages of the parasite life cycle that cause malarial disease. The identification of a parasite homologue of MIF raised the question of whether it affects monocyte function in a manner similar to its human counterpart. METHODS: Recombinant P. falciparum MIF (PfMIF) was generated and used in vitro to assess its influence on monocyte function. Antibodies generated against PfMIF were used to determine the expression profile and localization of the protein in blood-stage parasites. Antibody responses to PfMIF were determined in Kenyan children with acute malaria and in control subjects. RESULTS: PfMIF protein was expressed in asexual blood-stage parasites, localized to the Maurer's cleft. In vitro treatment of monocytes with PfMIF inhibited random migration and reduced the surface expression of Toll-like receptor (TLR) 2, TLR4, and CD86. CONCLUSIONS: These results indicate that PfMIF is released during blood-stage malaria and potentially modulates the function of monocytes during acute P. falciparum infection.
Subject(s)
Intramolecular Oxidoreductases/chemistry , Macrophage Migration-Inhibitory Factors/chemistry , Plasmodium falciparum/physiology , Protozoan Proteins/chemistry , Animals , Antibody Formation , Blotting, Northern , Cloning, Molecular , DNA Primers , Enzyme-Linked Immunosorbent Assay , Erythrocytes/parasitology , Humans , Inflammation , Intramolecular Oxidoreductases/immunology , Intramolecular Oxidoreductases/isolation & purification , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/immunology , Macrophage Migration-Inhibitory Factors/isolation & purification , Malaria, Falciparum/epidemiology , Malaria, Falciparum/physiopathology , Monocytes/parasitology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Protozoan Proteins/isolation & purificationABSTRACT
Macrophage migration inhibitory factor (MIF) is a pro-inflammatory mediator with the ability to induce various immunomodulatory responses and override glucocorticoid-driven immunosuppression. Some of these functions have been linked to the unusual enzymatic properties of the protein, namely tautomerase and oxidoreductase activities. However, there are conflicting reports regarding the functional role of these enzymatic properties in normal physiological homeostasis and disease progression. Therefore, we have produced a highly pure, virtually endotoxin-free recombinant MIF preparation and fully characterized this using a variety of biochemical and biophysical approaches. The recombinant protein, with demonstrable enzymatic activity, was then used to systematically examine the biological activity of MIF. Surprisingly, treatment with MIF alone failed to induce cytokine expression, with the exception of IL-8. However, co-treatment of lipopolysaccharide (LPS) in conjunction with MIF produced synergistic secretion of tumor necrosis factor-alpha, interleukin (IL)-1, and IL-8 compared with LPS alone. The potentiating effect of MIF was seen at physiologically relevant concentrations. These data suggest that MIF has no conventional cytokine activity but, rather, acts to modulate and amplify the response to LPS.
Subject(s)
Inflammation Mediators/isolation & purification , Inflammation Mediators/physiology , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/physiology , Animals , Cell Line , Cell Movement/immunology , Cell Survival/immunology , Cytokines/biosynthesis , Cytokines/genetics , Cytokines/isolation & purification , Cytokines/physiology , Drug Synergism , Granulocytes/cytology , Granulocytes/immunology , Humans , Inflammation Mediators/chemistry , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , Lipopolysaccharides/pharmacology , Macrophage Migration-Inhibitory Factors/genetics , Rats , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Recombinant Proteins/pharmacologyABSTRACT
Kinetics of thermal aggregation of model protein substrates (glycogen phosphorylase b from rabbit skeletal muscle and yeast alcohol dehydrogenase) were investigated under heat stress conditions (41-48 degrees C) in the presence of macrophage migration inhibitory factor (MIF), a heat-stable hydrophobic protein (12.5 kD). Anti-chaperone MIF activity found by turbidimetry manifests itself in significantly accelerated protein aggregation and increased limiting value of apparent optical absorption at 360 nm and t --> infinity in the sub-stoichiometric range of MIF concentrations. The aggregation kinetics is shown to have cooperative character. Possible reversibility of aggregation after removal of denaturing conditions was demonstrated using alcohol dehydrogenase aggregation at a temperature close to the physiological level (41.5 degrees C). This reversibility is caused by solubility of aggregates and stabilization of oligomeric structure of the substrate as a result of MIF binding to the partially denatured protein. The data suggest that in spite of distinct anti-chaperone effect, the chaperone-like activity of MIF can be observed in the case of heat stress removal and restoration of the system to normal conditions.
Subject(s)
Alcohol Dehydrogenase/metabolism , Glycogen Phosphorylase, Muscle Form/metabolism , Hot Temperature , Macrophage Migration-Inhibitory Factors/chemistry , Oxidative Stress , Alcohol Dehydrogenase/chemistry , Animals , Brain Chemistry , Cattle , Electrophoresis, Polyacrylamide Gel , Glycogen Phosphorylase, Muscle Form/chemistry , Heat-Shock Proteins/chemistry , Heat-Shock Proteins/metabolism , Kinetics , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/physiology , Muscle, Skeletal/enzymology , Rabbits , Saccharomyces cerevisiae/enzymologyABSTRACT
The purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol and its partial characterization are reported. A rapid and relatively simple method for MIF isolation was developed based mainly on size-exclusion chromatography on Toyopearl TSK polymer having a tendency to adsorb MIF as compared to elution of other proteins with similar molecular weights. The method gives a high yield of MIF (0.1 mg homogenous protein per g wet tissue). The retardation is conveniently utilized to achieve good separations of MIF from other proteins of similar molecular weights. The isolated protein was identified as MIF by SDS-electrophoresis, immunoblotting, sequencing of the N-terminal amino acid residues, and also by determination of keto-enol tautomerase activity that is characteristic of MIF with p-hydroxyphenylpyruvic acid as a substrate.
Subject(s)
Brain Chemistry , Chromatography, Gel/methods , Macrophage Migration-Inhibitory Factors/isolation & purification , Animals , Cattle , Cytosol/chemistry , Electrophoresis, Polyacrylamide Gel , Immunoblotting , Macrophage Migration-Inhibitory Factors/chemistry , Macrophage Migration-Inhibitory Factors/metabolism , Phenylpyruvic Acids/metabolism , Protein IsoformsABSTRACT
Macrophage migration inhibitory factor (MIF) is known as a ubiquitous pluripotent cytokine originally identified for its capacity to inhibit the random migration of macrophages in vitro. It is recognized as an important regulator of the immunological, neuroendocrine and enzymatic processes. MIF is widely expressed in brain, but its role in the nervous system is not yet understood. In the course of the study of the primary structure of bovine brain MIF we have previously identified a number of MIF-related proteins having identical N-terminal sequences. In this paper we report the results of isoelectric focusing of MIF isolated to a homogeneous state from bovine brain that revealed MIF charge heterogeneity. We have detected isoelectric forms of MIF with pI values of 6.9, 7.0, 7.3, and 7.8. The diverse actions of MIF within the immuno-neuroendocrine system is suggested to be a result of its occurrence in different isoforms and oligomerization states.
Subject(s)
Brain Chemistry , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/physiology , Animals , Cattle , Isoelectric Focusing/methods , Protein Isoforms/isolation & purification , Protein Isoforms/physiology , Static ElectricityABSTRACT
OBJECTIVE: To clone and express a homologue of human macrophage migration inhibitory factor (MIF) from P. falciparum 3D7--PfMIF. METHODS: The nucleotide sequence of PfMIF was found through blast P. falciparum genomic sequence databases with the amino acid sequence of human MIF (HuMIF). RT-PCR, DNA sequencing, and bioinformatics analysis were used for the cloning of Pfmif gene. The recombinant protein was expressed in E. coli and purified through the affinity column. RESULTS: The full length of Pfmif gene was cloned and sequenced. It was composed of 351 nucleotides and encoded 116 amino acids with the typical characteristic of MIF family. The recombinant protein was successfully expressed and purified. CONCLUSIONS: The Pfmif gene and recombinant protein were successfully isolated and PfMIF was preliminarily identified as a novel member of MIF family.
Subject(s)
Macrophage Migration-Inhibitory Factors/genetics , Plasmodium falciparum/genetics , Protozoan Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Escherichia coli/genetics , Humans , Macrophage Migration-Inhibitory Factors/biosynthesis , Macrophage Migration-Inhibitory Factors/isolation & purification , Molecular Sequence Data , Plasmodium falciparum/metabolism , Protozoan Proteins/biosynthesis , Protozoan Proteins/isolation & purification , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Sequence Homology, Amino AcidABSTRACT
OBJECTIVE: We have included migration inhibitory factor (MIF) in an ongoing immunohistochemical study comparing the site and intensity of the generation of inflammatory mediators in falciparum malaria, sepsis, and other causes of pediatric death in Africa. We wanted to determine whether it could account for our observation that inducible nitric oxide synthase is less strongly induced in the cerebral, compared with the systemic, vasculature. DATA SOURCES: Comparisons of tissue samples taken from blood vessel walls from the brain and the axillary space in a series of sepsis and falciparum malaria autopsies of African children. DATA SUMMARY: Intense staining for MIF has been detected in endothelial cells of axillary region vessels of all sepsis cases and most of the malaria cases examined. This parallels our findings with inducible nitric oxide synthase staining. African and Western control tissues from noninfectious causes of death stained lightly or not at all. In contrast, MIF could not be detected in vascular endothelial cells within the brain, where inducible nitric oxide synthase staining was much less intense. Detection of both MIF and inducible nitric oxide synthase in ependymal and glial cells in the same brains served as an internal positive staining control. CONCLUSION: These outcomes add weight to the proposal that endothelial cells are a site of intense inflammatory mediator activity in sepsis and malaria. They also suggest that suppression of anti-inflammatory glucocorticoids by MIF may be lower in the brain than elsewhere in the body. The lack of MIF in cerebral vasculature endothelial cells may be linked to the absence of thrombomodulin in these cells. The systemic cellular distribution and intensity of MIF in human systemic inflammatory states has not been described.
Subject(s)
Brain/metabolism , Endothelium, Vascular/metabolism , Macrophage Migration-Inhibitory Factors/metabolism , Malaria, Falciparum/metabolism , Sepsis/metabolism , Adult , Brain/pathology , Child , Child, Preschool , Enzyme Induction , Humans , Infant , Macrophage Migration-Inhibitory Factors/isolation & purification , Malaria, Falciparum/enzymology , Malaria, Falciparum/pathology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II , Sepsis/enzymology , Sepsis/pathologyABSTRACT
Studying tick feeding and digestion, we discovered in a cDNA library from partially fed Amblyomma americanum ticks the first known arthropod homologue of a human cytokine, the pro-inflammatory Macrophage Migration Inhibitory Factor (MIF). The tick origin of the MIF cDNA clone was confirmed by sequencing a genomic fragment that contained the full-length tick MIF gene with two introns. Antiserum to a tick MIF-specific peptide as well as antiserum to complete tick MIF revealed the expression of tick MIF in the salivary gland and midgut tissues of A. americanum ticks. In an in vitro functional assay, recombinant tick MIF inhibited the migration of human macrophages to the same extent that recombinant human MIF did.
Subject(s)
Cytokines/genetics , Macrophage Migration-Inhibitory Factors/genetics , Ticks/genetics , Amino Acid Sequence , Animals , Antibody Specificity , Arthropod Proteins , Base Sequence , Cytokines/classification , Cytokines/isolation & purification , Cytokines/physiology , DNA, Complementary , Female , Gene Expression , Humans , Macrophage Migration-Inhibitory Factors/classification , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/physiology , Macrophages/physiology , Molecular Sequence Data , Rabbits , Sequence Homology, Amino Acid , Ticks/immunology , Tissue DistributionABSTRACT
BACKGROUND: The cytokine macrophage migration inhibitory factor (MIF), originally described as a T cell product, has recently been identified to mediate cellular interactions in several endocrine organs. Western blots analysis of rat epididymal homogenates using an anti-MIF antibody indicated the presence of substantial amounts of an immunoreactive protein with the apparent Mr of 12 kDa. Our study aimed to characterize the molecular nature of this immunoreactive factor. MATERIALS AND METHODS: The purified 12 kDa protein and a cloned cDNA fragment were characterized by sequence analysis. Furthermore, expression pattern and localization of the 12 kDa protein were investigated using in situ hybridization, immunohistochemistry, immunoelectron microscopy, and western blots experiments on epididymal sections, isolated epididymal vesicles, and outer dense fibers from spermatozoa. RESULTS: The N-terminal amino acid sequence analysis over 10 amino acids revealed a 100% homology of the 12 kDa protein to the N-terminus of the cytokine MIF. These data were confirmed by sequence analysis of a reverse transcription polymerase chain reaction (RT-PCR) amplified cDNA fragment from rat epididymis, which also showed complete homology to the MIF cDNA sequence. MIF protein and mRNA were localized in the epithelial cells of the epididymis in a regional distribution manner, with the expression maximal in the caput. Immune cells were not labeled. MIF is the first classical cytokine identified to be expressed by the epididymal epithelial cells. Immunoelectron microscopy detected MIF immunoreactivity in the cytoplasm, with no reaction visible in the Golgi complex and the cisternae of the endoplasmic reticulum. At the apical cell surface, MIF accumulated in stereocilia and vesicles that were pinched off from the plasma membrane. MIF detection in vesicles isolated from epididymal secretion together with the lack of a N-terminal signal sequence for translocation in the endoplasmic reticulum strongly suggested a nonclassical secretion mode. Furthermore, MIF was identified as a new component of the outer dense fibers (ODF), a cytoskeletal element of the mid- and principal piece of the sperm tail. CONCLUSION: The cytokine MIF was identified in substantial amounts in the epithelial cells of rat epididymis and in the outer dense fibers of rat epididymal spermatozoa. Our results indicate a nonclassical secretion mode for MIF and suggest a cell-to-cell transfer of MIF via vesicles to the sperm cells.
Subject(s)
Epididymis/metabolism , Macrophage Migration-Inhibitory Factors/isolation & purification , Macrophage Migration-Inhibitory Factors/physiology , Spermatozoa/metabolism , Animals , Immunohistochemistry/methods , Male , Microscopy, Immunoelectron , RNA, Messenger/metabolism , RatsABSTRACT
In the course of the study of the primary structures and molecular mechanisms of action of immunologically active compounds of the nervous system we have isolated from the soluble fraction of total bovine brain two heat-stable proteins. The purification procedure was mainly based on DEAE-Servacel ion-exchange chromatography and reversed-phase HPLC. The proteins were identified by the N-terminal Edman microsequence analysis and database searching as macrophage migration inhibitory factor (MIF). The N-terminal sequences for MIF1 and MIF2 were found to be identical. According to mass spectral analysis, the molecular masses for MIF1 and MIF2 were determined respectively as 12,369.21 and 12,299.7 Da. In addition, we have also isolated a third peptide having the same N-terminal sequence and Mr 9,496.2 that seems to be a proteolytic fragment of MIF. Using p-hydroxyphenylpyruvate as a substrate, we have not revealed tautomerase activity of either MIF1 or MIF2. As both the immunologic and enzymatic activities were reported to be expressed by the oligomeric structure of MIF, we suggest that the present study may give additional information on MIF in terms of structural properties of this protein. A comparatively simple purification procedure is presented that may be widely used for simultaneous isolation in one run of MIF isoforms.